|
1
|
Nishino I, Fu J, Tanji K, Yamada T,
Shimojo S, Koori T, Mora M, Riggs JE, Oh SJ, Koga Y, et al: Primary
LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and
myopathy (Danon disease). Nature. 406:906–910. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sugie K, Yamamoto A, Murayama K, Oh SJ,
Takahashi M, Mora M, Riggs JE, Colomer J, Iturriaga C, Meloni A, et
al: Clinicopathological features of genetically confirmed danon
disease. Neurology. 58:1773–1778. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boucek D, Jirikowic J and Taylor M:
Natural history of Danon disease. Genet Med. 13:563–568. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu Y, Wang F, Chen X, Liang Y, Deng H,
Liao H, Rao F, Wei W, Zhang Q, Zhang B, et al: Fasciculoventricular
pathways responsible for ventricular preexcitation in patients with
danon disease. Circ Arrhythm Electrophysiol. 11:e0067042018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rowin EJ, Maron BJ, Kiernan MS, Casey SA,
Feldman DS, Hryniewicz KM, Chan RH, Harris KM, Udelson JE, DeNofrio
D, et al: Advanced heart failure with preserved systolic function
in nonobstructive hypertrophic cardiomyopathy: Under-recognized
subset of candidates for heart transplant. Circ Heart Fail.
7:967–975. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fu L, Luo S, Cai S, Hong W, Guo Y, Wu J,
Liu T, Zhao C, Li F, Huang H, et al: Identification of LAMP2
mutations in early-onset danon disease with hypertrophic
cardiomyopathy by targeted next-generation sequencing. Am J
Cardiol. 118:888–894. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Taylor MR, Ku L, Slavov D, Cavanaugh J,
Boucek M, Zhu X, Graw S, Carniel E, Barnes C, Quan D, et al: Danon
disease presenting with dilated cardiomyopathy and a complex
phenotype. J Hum Genet. 52:830–835. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dougu N, Joho S, Shan L, Shida T, Matsuki
A, Uese K, Hirono K, Ichida F, Tanaka K, Nishino I and Inoue H:
Novel LAMP-2 mutation in a family with Danon disease presenting
with hypertrophic cardiomyopathy. Circ J. 73:376–380. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Arad M, Maron BJ, Gorham JM, Johnson WH,
Saul JP, Perez-Atayde AR, Spirito P, Wright GB, Kanter RJ, Seidman
CE and Seidman JG: Glycogen storage diseases presenting as
hypertrophic cardiomyopathy. N Engl J Med. 352:362–372. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Majer F, Vlaskova H, Krol L, Kalina T,
Kubanek M, Stolnaya L, Dvorakova L, Elleder M and Sikora J: Danon
disease: A focus on processing of the novel LAMP2 mutation and
comments on the beneficial use of peripheral white blood cells in
the diagnosis of LAMP2 deficiency. Gene. 498:183–195. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sugie K, Yoshizawa H, Onoue K, Nakanishi
Y, Eura N, Ogawa M, Nakano T, Sakaguchi Y, Hayashi YK, Kishimoto T,
et al: Early onset of cardiomyopathy and intellectual disability in
a girl with Danon disease associated with a de novo novel mutation
of the LAMP2 gene. Neuropathology. 36:561–565. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen XL, Zhao Y, Ke HP, Liu WT, Du ZF and
Zhang XN: Detection of somatic and germline mosaicism for the LAMP2
gene mutation c.808dupG in a Chinese family with danon disease.
Gene. 507:174–176. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hedberg Oldfors C, Mathe G, Thomson K,
Tulinius M, Karason K, Östman-Smith I and Oldfors A: Early onset
cardiomyopathy in females with Danon disease. Neuromuscul Disord.
25:493–501. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schorderet DF, Cottet S, Lobrinus JA,
Borruat FX, Balmer A and Munier FL: Retinopathy in Danon disease.
Arch Ophthalmol. 125:231–236. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Danon MJ, Oh SJ, DiMauro S, Manaligod JR,
Eastwood A, Naidu S and Schliselfeld LH: Lysosomal glycogen storage
disease with normal acid maltase. Neurology. 31:51–57. 1981.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Burusnukul P, de Los Reyes EC, Yinger J
and Boué DR: Danon disease: An unusual presentation of autism.
Pediatr Neurol. 39:52–54. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
López-Sainz A, Salazar-Mendiguchía J,
Garcia-Alvarez A, Campuzano Larrea O, Lopez-Garrido MÁ,
Garcia-Guereta L, Fuentes Cañamero ME, Climent Payá V, Pena-Peña
ML, Zorio-Grima E, et al: Clinical findings and prognosis of danon
disease. An analysis of the Spanish multicenter danon Registry. Rev
Esp Cardiol (English, Spanish). 72:479–486. 2018. View Article : Google Scholar
|
|
18
|
Konrad T, Sonnenschein S, Schmidt FP,
Mollnau H, Bock K, Ocete BQ, Münzel T, Theis C and Rostock T:
Cardiac arrhythmias in patients with danon disease. Europace.
19:1204–1210. 2017.PubMed/NCBI
|
|
19
|
García Seara FJ, Martínez Sande JL, Cid
Alvarez B and González Juanatey JR: Wolff-Parkinson-White's
syndrome and danon's disease. Med Clin (Barc) (Spanish).
130:2772013. View
Article : Google Scholar
|
|
20
|
D'Souza RS, Mestroni L and Taylor MRG:
Danon disease for the cardiologist: Case report and review of the
literature. J Community Hosp Intern Med Perspect. 7:107–114. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Spinazzi M, Fanin M, Melacini P,
Nascimbeni AC and Angelini C: Cardioembolic stroke in danon
disease. Clin Genet. 73:388–390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
D'Souza RS, Levandowski C, Slavov D, Graw
SL, Allen LA, Adler E, Mestroni L and Taylor MR: Danon disease:
Clinical features, evaluation, and management. Circ Heart Fail.
7:843–849. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bertini E, Donati MA, Broda P, Cassandrini
D, Petrini S, Dionisi-Vici C, Ballerini L, Boldrini R, D'Amico A,
Pasquini E, et al: Phenotypic heterogeneity in two unrelated Danon
patients associated with the same LAMP-2 gene mutation.
Neuropediatrics. 36:309–313. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lines MA, Hewson S, Halliday W, Sabatini
PJ, Stockley T, Dipch AI, Bowdin S and Siriwardena K: Danon disease
due to a novel LAMP2 microduplication. JIMD Rep. 14:11–16. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Miani D, Nucifora G, Piccoli G, Proclemer
A and Badano LP: Incremental value of three-dimensional strain
imaging in danon disease. Eur Heart J Cardiovasc Imaging.
13:8042012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Piotrowska-Kownacka D, Kownacki L, Kuch M,
Walczak E, Kosieradzka A, Fidzianska A and Krolicki L:
Cardiovascular magnetic resonance findings in a case of danon
disease. J Cardiovasc Magn Reson. 11:122009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Le DD, Alvarez P, Barrios R, Arriaga M,
Cherry M, Shah D and Lin CH: Hypertrophic cardiomyopathy with
unusual extensive scarring pattern: Danon disease. Methodist
DeBakey Cardiovasc J. 12:227–229. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kitahara H, Nawata K, Kinoshita O, Itoda
Y, Shintani Y, Fukayama M and Ono M: Implantation of a left
ventricular assist device for danon cardiomyopathy. Ann Thorac
Surg. 103:e39–e41. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zaki A, Zaidi A, Newman WG and Garratt CJ:
Advantages of a subcutaneous implantable cardioverter-defibrillator
in LAMP2 hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol.
24:1051–1053. 2013. View Article : Google Scholar : PubMed/NCBI
|
